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Abstract
Background: Plasmodium falciparum malaria remains a major cause of illness and death in sub-Saharan Africa. Young
children bear the brunt of the disease and though older children and adults suffer relatively fewer clinical attacks, they
remain susceptible to asymptomatic P. falciparum infection. A better understanding of the host factors associated with
immunity to clinical malaria and the ability to sustain asymptomatic P. falciparum infection will aid the development of
improved strategies for disease prevention.
Methods and Findings: Here we investigate whether full differential blood counts can predict susceptibility to clinical
malaria among Kenyan children sampled at five annual cross-sectional surveys. We find that the ratio of monocytes to
lymphocytes, measured in peripheral blood at the time of survey, directly correlates with risk of clinical malaria during
follow-up. This association is evident among children with asymptomatic P. falciparum infection at the time the cell counts
are measured (Hazard ratio (HR) = 2.7 (95% CI 1.42, 5.01, P = 0.002) but not in those without detectable parasitaemia (HR
= 1.0 (95% CI 0.74, 1.42, P = 0.9).
Conclusions: We propose that the monocyte to lymphocyte ratio, which is easily derived from routine full differential blood
counts, reflects an individual’s capacity to mount an effective immune response to P. falciparum infection.
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Introduction
Plasmodium falciparum malaria is still a major cause of morbidity
and mortality in sub-Saharan Africa where the greatest burden of
disease is borne by young children [1,2]. Substantial clinical
immunity develops following repeated natural exposure to P.
falciparum such that clinical malaria tends to be less frequent in
children over 5 years of age and adults. Despite this, older children
and adults remain susceptible to asymptomatic, often chronic, P.
falciparum infections to which immunity probably never occurs
[3,4]. This distinction between immunity to clinical malaria and
immunity against P. falciparum infection per se is further evident in
the epidemiological pattern of clinical malaria and asymptomatic
parasitaemia in areas endemic for P. falciparum transmission. Whilst
the frequency of clinical malaria among individuals resident in
these settings tends to be highly seasonal, that of asymptomatic P.
falciparum infections remains relatively constant throughout the
year [3,4]. Thus, as proposed previously [5], individuals with pre-
existing asymptomatic P. falciparum infection must often develop
clinical malaria perhaps following infection by parasites with
different antigenic properties from those associated with the
asymptomatic infection. The specific host factors underlying
susceptibility to clinical malaria despite the ability to sustain
asymptomatic P. falciparum infection are poorly understood.
Longitudinal studies in which individuals are recruited at cross-
sectional surveys and their risk of developing disease assessed in a
defined follow-up period have been a key tool in identifying
correlates of immunity to clinical malaria [6]. Several factors,
assessed at the time of recruitment to such studies, have been
shown to modify an individual’s risk of clinical malaria in the
follow-up period. These include age, antibodies to certain parasite
blood-stage antigens and, carriage of asymptomatic P. falciparum
infection at the time of survey, among others [2,7–9]. The levels of
specific immune responses among children with asymptomatic P.
falciparum infection at the time of survey have been observed to be
higher and to exhibit stronger correlation with reduced risk of
disease during follow-up when compared to responses in children
without detectable parasitaemia [8,10–12]. These data have
highlighted the need for accounting for asymptomatic parasitae-
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mia in studies using a longitudinal framework to identify correlates
of immunity to clinical malaria.
Full differential cell counts from peripheral blood are routinely
used as an aid to clinical diagnosis of a wide range of infectious
diseases, including malaria, where they have been associated with
prognosis in several studies [13–16]. However, their utility as a
correlate of disease risk in longitudinal studies has been poorly
investigated. Given the central role of monocytes and lymphocytes
in the induction of immune responses, their frequency in
peripheral blood might be expected to reflect the state of an
individual’s immune response to infection. In a recent transcrip-
tional analysis of peripheral blood mononuclear cells from a
cohort of South African infants the relative frequency of myeloid-
specific to lymphoid-specific transcripts at the start of monitoring
was shown to predict risk of developing tuberculosis disease during
follow-up (H.A.F. and A.V.S.H., unpublished data). Here, using
full differential blood count data from Kenyan children included
in five cross-sectional surveys, we sought to determine whether the
relative count of monocytes to lymphocytes in peripheral blood
(hereafter termed ‘‘ML ratio’’) can identify children at most risk of
developing clinical malaria during follow-up. We find that among
children with asymptomatic P. falciparum infection at the time their
full differential blood counts are measured, high ML ratio is
associated with an increased risk of clinical malaria episodes
during follow-up.
Materials and Methods
Ethics statement
The Kenya Medical Research Institute National Ethical Review
committee granted approval for this study. Written informed
consent was obtained from parents or guardians of all study
participants.
Study location and population
This study was conducted at Kilifi District Hospital on cohort
data from children resident in Junju sub-location of Kilifi district,
Kenya, and is part of the Kilifi Health and Demographic
Surveillance System [17]. As of 2010, Junju had an estimated
entomological inoculation rate of 21.7 [18] though malaria
transmission in the wider Kilifi district has been on the decline
since 1999 [19]. Cohort data from children included in five annual
cross-sectional surveys performed just before the rainy season in
May 2007, 2008, 2009, 2010 and 2011, respectively, were used.
Blood samples were collected from each individual in the
respective surveys and a full differential blood count performed
using a Coulter CounterH (Beckman Coulter, Inc.). In addition
thick and thin blood smears were made, Giemsa-stained and
examined for P. falciparum parasites by microscopy. Children that
were febrile at the time of survey, whether carrying parasites in
peripheral blood (‘‘parasite positive’’) or not (‘‘parasite negative’’),
were treated appropriately by a clinician at the Kilifi District
Hospital and excluded from this study. No treatment was
administered to asymptomatic parasite positive children. A
summary of the numbers of parasite positive and parasite negative
children included in this study from each of the five surveys and
their respective characteristics are shown in Table 1.
Monitoring for clinical malaria episodes
Weekly active surveillance was used to monitor episodes of
clinical malaria by trained field-workers. In addition, passive
surveillance was undertaken by trained field-workers based at
villages across the study area and at local dispensaries. Monitoring
for parasites was only done in children with a history of fever. ML
ratios were not measured at the time of clinical malaria episodes.
Detailed surveillance procedures have been published previously
[18,20]. Clinical malaria was defined as fever (axillary temperature
$37.5 uC) plus any parasite density for children under 1 year old
and fever accompanied by parasite density .2500 parasites/ml of
blood for all other children [21].
Statistical analysis
All analyses were done in StataTM version 11 and P value,0.05
used as the cut-off for statistical significance. Negative binomial
regression models were used to estimate the associations between
clinical malaria episodes and explanatory variables, offset by the
period of observation during which children were at risk of clinical
malaria. The risk period was defined as the period between date of
recruitment to cross-sectional survey and either the date when an
individual was lost to follow-up or 31st December 2011. Observed
associations were then confirmed using unadjusted Cox regression
models to estimate the relationship between explanatory variables
and time to first clinical malaria episode. Where data from all five
cohorts were considered in the Cox regression modeling, ML ratio
or the respective cell count data were included as time-varying
covariates.
The May 2008 cross-sectional survey was used as the baseline
survey for the primary analysis since children sampled at this time
point had antibody data available, allowing adjustment for known
antibody correlates of immunity to malaria. First, full differential
blood count data from the 319 children sampled at the May 2008
baseline survey were used to estimate the association between ML
ratio and total number of clinical malaria episodes experienced
during the period between sampling at the May 2008 baseline
survey and either the date when an individual was lost to follow-up
or 31st December 2011. Then, the effect of adjustment for age and
antibodies to the parasite blood-stage antigens apical membrane
antigen 1 (AMA1) and merozoite surface proteins 2 (MSP2) and 3
(MSP3), respectively, was examined. Finally, to assess the temporal
stability of observed associations between ML ratio and risk of
clinical malaria, full differential blood count data from children
sampled in the May 2008 survey (N = 319) or in any of four other
cross-sectional surveys conducted in May 2007 (N = 319), 2009
(N = 332), 2010 (N = 327) and 2011 (N = 356), respectively,
were used. The number of clinical malaria episodes in the
respective inter-survey periods (that is, between May 2007 and
May 2008, May 2008 and May 2009, May 2009 and May 2010,
May 2010 and May 2011 and, May 2011 and 31st December
2011) were used as the dependent variable in the negative
binomial regression modeling while accounting for: i) multiple
sampling of individuals recruited into more than one survey using
the robust sandwich estimator, ii) the year of survey as a fixed
effect and, iii) age at each survey as a continuous variable.
Results
A total of 762 episodes of clinical malaria (range, 0 – 6 per child)
were experienced over the entire duration of the study, that is,
between survey at May 2007 and 31st December 2011. Parasite
positive children accounted for fewer of these episodes (121
compared to 641 in parasite negative children). In a negative
binomial model predicting frequency of clinical malaria episodes
using parasite positive/negative status while accounting for age,
year of survey and multiple sampling of individuals, carriage of
asymptomatic P. falciparum infection at survey was associated with
reduced risk of clinical malaria (Incidence rate ratio (IRR) = 0.7,
95% confidence interval (CI) 0.56, 0.85, P = 0.0004).
Monocyte to Lymphocyte Ratio and Malaria Risk
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ML ratio at baseline survey is positively associated with
risk of clinical malaria during follow-up
To assess the relationship between ML ratio and risk of clinical
malaria we first used the May 2008 survey as baseline since
antibody data were available for children sampled at this time,
allowing adjustment for known antibody correlates of immunity to
malaria. Whereas all models were adjusted for age, associations
were first estimated before adjustment for antibodies and the effect
of this adjustment assessed thereafter.
High ML ratios were associated with high frequency of clinical
episodes among children parasite positive at baseline (IRR = 2.2,
95%CI 1.10, 4.50, P = 0.03; unadjusted for antibodies) but no
association was observed among children parasite negative at
baseline (IRR = 0.8, 95% CI 0.58, 1.17, P = 0.3; unadjusted for
antibodies). Survival analysis using time to first episode as the
primary endpoint confirmed the association between high ML
ratio and risk of clinical malaria (Fig. 1A–B). Furthermore, the
interaction between parasite positive/negative status at baseline
and ML ratio was found to be statistically significant (IRR = 2.6,
95%CI 1.28, 5.40, P = 0.008; unadjusted for antibodies).
There was no correlation between ML ratio and age at
recruitment among parasite positive (rho = 20.05, P = 0.6) or
among parasite negative children (rho = 0.06, P = 0.4). We
considered the possibility that the association between ML ratio
and disease might act through an association between ML ratio
and protective antibodies to certain P. falciparum blood-stage
antigens [8]. If this were the case we would predict that the
association between ML ratio and total episode count would not
be significant following adjustment for antibody levels. Total IgG
antibody data, measured using a published enzyme-linked
immunosorbent assay protocol [8], from 288 children sampled
at the same time as the ML ratio data in the May 2008 baseline
survey were available for the blood-stage antigens AMA1, MSP2
and MSP3, respectively. Antibodies to AMA1 and MSP3, but not
MSP2, correlated with reduced risk of clinical malaria episodes
(Table 2). However, adjusting for these antibody variables did not
confound the association between high ML ratio and frequent
episodes of clinical malaria (Table 2). The independence of these
antibody measures and ML ratio in predicting risk of malaria
suggests that ML ratio modulates risk of clinical malaria through a
mechanism that is distinct from antibody production.
The association between high ML ratio and risk of clinical
malaria is stable over time
We next investigated the relationship between ML ratio and risk
of clinical malaria over time using both the ML ratios measured at
the May 2008 baseline survey and those measured at each of four
other surveys carried out in May 2007, 2009, 2010 and 2011,
respectively. Overall, the range of ML ratios measured at the
different surveys was comparable across the five surveys (Table 1).
Table 1. Summary characteristics of the study population.
Year of survey Variable Parasite negative (Median, IQR) Parasite positive (Median, IQR)
2007 Number sampled 269 50
Age (years) 4.5 (3.1, 6.4) 5.8 (4.1, 6.6)
Monocyte count (x103/ml of blood) 0.64 (0.49, 0.86) 0.69 (0.49, 0.85)
Lymphocyte count (x103/ml of blood) 3.69 (2.87, 4.83) 3.78 (3.12, 4.39)
ML ratio 0.17 (0.14, 0.21) 0.19 (0.13, 0.22)
2008 Number sampled 226 93
Age (years) 5.0 (3.2, 7.1) 6.7 (5.1, 7.7)
Monocyte count (x103/ml of blood) 0.50 (0.37, 0.65) 0.46 (0.37, 0.58)
Lymphocyte count (x103/ml of blood) 3.26 (2.4, 4.52) 2.65 (2.00, 3.58)
ML ratio 0.15 (0.12, 0.19) 0.17 (0.13, 0.23)
2009 Number sampled 264 68
Age (years) 6.0 (3.7, 8.0) 7.2 (5.6, 8.5)
Monocyte count (x103/ml of blood) 0.59 (0.47, 0.76) 0.65 (0.49, 0.83)
Lymphocyte count (x103/ml of blood) 3.49 (2.85, 4.75) 3.50 (2.90, 4.25)
ML ratio 0.16 (0.13, 0.21) 0.19 (0.15, 0.23)
2010 Number sampled 242 85
Age (years) 6.5 (3.4, 9.1) 7.8 (6.6, 9.2)
Monocyte count (x103/ml of blood) 0.60 (0.47, 0.77) 0.63 (0.50, 0.76)
Lymphocyte count (x103/ml of blood) 3.44 (2.69, 4.43) 3.26 (2.58, 4.07)
ML ratio 0.18 (0.14, 0.22) 0.19 (0.15, 0.25)
2011 Number sampled 276 80
Age (years) 7.2 (3.6, 9.7) 9.2 (7.1, 10.7)
Monocyte count (x103/ml of blood) 0.61 (0.43, 0.92) 0.64 (0.53, 0.84)
Lymphocyte count (x103/ml of blood) 3.41 (2.70, 4.44) 3.18 (2.58, 3.88)
ML ratio 0.18 (0.13, 0.24) 0.20 (0.17, 0.26)
Presented are the medians and interquartile ranges (IQR) for age, monocyte count, lymphocyte count and ML ratio at the time of survey for children recruited in each
respective cross-sectional survey. The data are shown by year of survey and are stratified by parasite positive/negative status at the time of survey.
doi:10.1371/journal.pone.0057320.t001
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However, a positive correlation of ML ratios between different
surveys was only observed consistently when comparisons were
made between parasite negative children (Fig. 2) suggesting that
ML ratios are stable over time but only in the absence of P.
falciparum infection. Despite the statistical significance among
parasite negative children the Spearman’s rank correlation
coefficients were relatively low (all less than 0.50, Fig. 2). This
might be explained if some of the children classified as parasite
negative at cross-sectional survey had an asymptomatic P.
falciparum infection shortly before sampling at the survey, which
perturbed their ML ratio. However, monitoring for asymptomatic
P. falciparum infections was not done in this study and thus no firm
conclusions can be drawn regarding this possibility. Further, since
we used light microscopy rather than PCR-based parasite
detection methods it is plausible that some of the parasite negative
children might have had asymptomatic P. falciparum infection at
very low parasitaemia, below the detection limit of light
microscopy. Future studies monitoring asymptomatic P. falciparum
infections by the more sensitive PCR methods [22,23] will help
provide a better assessment of the extent to which ML ratios
fluctuate over time among children living in areas endemic for P.
falciparum.
To test whether the observed association between high ML ratio
and clinical malaria is stable over time we used the number of
Figure 1. ML ratio positively correlates with risk of clinical malaria. Kaplan-Meier plots of the relationship between ML ratio and time to first
episode of clinical malaria during follow-up is shown. (A) and (B) represent results using ML ratios measured in the May 2008 baseline survey and
consider a follow-up period ending on 31st December 2011. However, most parasite positive children had experienced their first clinical malaria
episode within a year since sampling in the May 2008 baseline survey and so the plots show data for the first 12 months of follow-up. (C) and (D)
represent results based on ML ratios measured at each of five surveys (May 2007, 2008, 2009, 2010 and 2011) and consider time to the first episode
within the respective one year inter-survey periods as the primary endpoint. The hazard ratios (HR) from unadjusted Cox regression models using ML
ratio as the only explanatory variable are shown. The cumulative proportion of children with malaria in relation to their ML ratio, stratified into three
arbitrary groups, is shown. ‘‘High ML ratio’’ and ‘‘Low ML ratio’’ represent children whose ML ratio falls in the top and bottom 25th percentile of the
sampled population, respectively, whilst ‘‘Medium ML ratio’’ represents all other children.
doi:10.1371/journal.pone.0057320.g001
Monocyte to Lymphocyte Ratio and Malaria Risk
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clinical malaria episodes in the respective inter-survey periods (that
is, between May 2007 and May 2008, May 2008 and May 2009,
May 2009 and May 2010, May 2010 and May 2011 and, May
2011 and 31st December 2011) as a dependent variable in the
negative binomial regression modeling while accounting for i)
multiple sampling of individuals recruited into more than one
survey using the robust sandwich estimator, ii) the year of survey as
a fixed effect and, iii) age at each survey as a continuous variable.
A positive association between ML ratio and risk of multiple
episodes of malaria was evident among children that were parasite
positive at the time of measuring their ML ratio (IRR = 2.0,
95%CI 1.27, 3.20, P = 0.003). No such association was observed
in parasite negative children (IRR = 1.1, 95%CI 0.86, 1.30, P =
0.6). These findings were again confirmed by survival analysis
Table 2. The association between risk of malaria and ML ratio is independent of age and antibodies to parasite blood-stage
antigens.
PARASITE NEGATIVE (N = 207) PARASITE POSITIVE (N = 81)
Analysis type Variable IRR (95% CI) P value IRR (95% CI) P value
Univariate ML ratio 0.8 (0.55, 1.17) 0.3 2.8 (1.48, 5.12) 0.001
Age 0.9 (0.88, 0.96) 0.0002 0.8 (0.69, 0.96) 0.02
AMA1 antibodies 0.3 (0.17, 0.64) 0.001 0.2 (0.10, 0.55) 0.0007
MSP2 antibodies 1.4 (1.01, 1.81) 0.04 0.8 (0.46, 1.56) 0.6
MSP3 antibodies 0.8 (0.29, 2.01) 0.6 0.3 (0.17, 0.69) 0.002
Parasite schizont extract 1.5 (1.20, 1.78) 0.0001 1.2 (0.72, 2.02) 0.5
Multivariate ML ratio 0.9 (0.61, 1.20) 0.4 2.2 (1.16, 4.28) 0.02
Age 0.9 (0.87, 0.96) 0.0002 0.8 (0.75, 0.96) 0.01
AMA1 antibodies 0.4 (0.17, 0.91) 0.03 0.3 (0.13, 0.83) 0.02
MSP2 antibodies 1.1 (0.75, 1.49) 0.7 1.1 (0.58, 2.09) 0.8
MSP3 antibodies 0.5 (0.26, 1.08) 0.08 0.4 (0.22, 0.85) 0.01
Parasite schizont extract 1.7 (1.35, 2.04) 0.000002 1.5 (1.00, 2.40) 0.05
Presented are incidence rate ratios (IRR) and 95% confidence intervals (CI) from negative binomial regression models predicting the total number of malaria episodes
between sampling at May 2008 baseline survey and 31st December 2011 using ML ratio, age, antibodies to AMA1, MSP2 and MSP3 and to parasite schizont extract, used
routinely as a control for previous parasite exposure in antibody assays [8]. Univariate analysis is done using each variable in turn whereas all variables are included in
the multivariate model and the respective results from each variable shown. As with the complete dataset on which the antibody data is based a statistically significant
interaction between parasite positive/negative status at baseline and ML ratio was evident (IRR = 2.7, 95%CI 1.32, 5.47, P = 0.006).
doi:10.1371/journal.pone.0057320.t002
Figure 2. Comparison between ML ratios measured at different cross-sectional surveys. Spearman rank correlation coefficient is used to
assess the relationship between ML ratios across different surveys according to parasite positive/negative status at the time the ML ratio was
measured. Results are shown for children that were parasite positive at the May 2007 or 2008 or 2009 or 2010 survey and parasite positive (A) or
parasite negative (B) in subsequent surveys (that is 2008–2011). In (C) and (D) results are shown for children that were parasite negative at the May
2007 or 2008 or 2009 or 2010 survey and parasite positive (C) or parasite negative (D) in subsequent surveys (that is 2008–2011). Rho values from all
comparisons are shown and statistically significant comparisons (P,0.05) indicated in shaded boxes. Unshaded boxes represent comparisons that
showed no significant correlation.
doi:10.1371/journal.pone.0057320.g002
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using time to first episode as an endpoint (Fig. 1C–D). The results
thus suggest that the relationship between ML ratio in children
with an ongoing asymptomatic P. falciparum infection and
susceptibility to frequent episodes of malaria is stable over time.
Monocyte and lymphocyte counts exhibit contrasting
associations with risk of clinical malaria
Next we sought to determine whether the association between
ML ratio and risk of clinical malaria was attributable to the
frequency of lymphocytes, monocytes or both cell types. To do this
we used both lymphocyte and monocyte count simultaneously as
explanatory variables for the negative binomial regression
modeling using data from all five cohorts while accounting for
multiple sampling of individuals, their age at time of sampling the
cell counts and year of survey. If only one cell type was responsible
for the association between ML ratio and clinical malaria we
would predict that, when both cell counts are used in place of ML
ratio for the regression modeling, an association would only be
evident with the frequency of the predominant cell type.
Neither lymphocyte count nor monocyte count showed an
association with clinical malaria among parasite negative children
(Monocyte count, IRR = 1.1, 95%CI 0.89, 1.35, P = 0.4;
Lymphocyte count, IRR = 1.0, 95%CI 0.76, 1.39, P = 0.9).
However, among parasite positive children, increased risk of
clinical malaria episodes was associated with a high monocyte
count (IRR = 1.7, 95%CI 1.02, 2.73, P = 0.04) and a low
lymphocyte count (IRR = 0.3, 95%CI 0.19, 0.63, P = 0.0005).
This is in agreement with the high monocyte count and low
lymphocyte count observed in previous studies of children
presenting to hospital with clinical malaria [14,16]. The observed
pattern of associations was again confirmed using Cox regression
with time to first clinical episode as an endpoint among parasite
negative children (Monocyte count, HR = 1.0, 95%CI 0.73, 1.45,
P = 0.9; Lymphocyte count, HR = 1.0, 95%CI 0.66, 1.48, P =
0.9) and among parasite positive children (Monocyte count, HR
= 2.4, 95%CI 1.25, 4.72, P = 0.009; Lymphocyte count, HR =
0.3, 95%CI 0.14, 0.69, P = 0.004).
Discussion
Collectively our data suggests that in the context of an ongoing
infection by malaria parasites, the relative frequency of monocytes
to lymphocytes in peripheral circulation reflects an individual’s
capacity to mount an effective immune response. This is not
surprising given that monocytes are an essential component of the
innate immune response that acts as a link to the adaptive immune
system through antigen presentation to lymphocytes. Thus any
factors that perturb the function or relative frequency of either cell
type could potentially affect an individual’s response to infection.
So why is the association between ML ratio and risk of clinical
malaria only evident among parasite positive children?
Derangement in monocyte or lymphocyte function or frequency
is likely to be most evident during an infection, and this may be
supported by the observation that ML ratios were consistently
higher among parasite positive children in all five cross-sectional
surveys (see Table 1). Thus, one possible explanation is that ML
ratio is a marker of an individual’s capacity to mount an effective
immune response against clinical malaria but that it is most
informative during an on-going parasite challenge. However, the
possibility that presence of asymptomatic parasitaemia at survey
merely reflects more frequent exposure to P. falciparum that allows
greater power to detect associations between ML ratio and clinical
malaria needs to be ruled out.
The innate immune response, through pro-inflammatory
cytokines such as IFNc, is thought to contribute to the initial
control of parasitaemia following infection by P. falciparum, but to
also correlate with development of clinical symptoms [24,25]. This
has led to the notion that such a predominantly anti-parasitic
immune response requires tempering by the adaptive immune
response if effective immunity to clinical malaria is to be achieved.
In fact, mounting evidence suggests that the balance of pro- and
anti-inflammatory immune responses following exposure to
malaria parasites may be an important factor in determining
clinical protection [25–28]. It is plausible that the ML ratio reflects
where in the spectrum of these immune responses an individual is.
Hence in the presence of an ongoing asymptomatic infection, a
high ML ratio might indicate a predominantly pro-inflammatory
immune response that renders individuals susceptible to clinical
malaria, but with repeated exposure to P. falciparum the adaptive
immune response ‘‘learns’’ to produce anti-inflammatory cytokines
that effectively temper the pro-inflammatory immune response,
leading to a lower ML ratio and prevention of immunopathology.
Assessment of the relationship between ML ratio and cellular
immune responses is clearly needed if the mechanism underlying
the association between elevated ML ratio and susceptibility to
clinical episodes of malaria is to be determined.
Our study had several limitations. First, though we used data
from children sampled at five annual cross-sectional surveys, both
the ML ratios and parasite positive/negative status were measured
at a single time-point within any year. Second, monitoring was not
done for asymptomatic P. falciparum infections hence there is no
way of telling whether some children harbored asymptomatic
infections in the previous week(s) during monitoring for clinical
episodes or shortly before sampling of ML ratios at cross-sectional
survey. This is further compounded by the possibility that our
microscopy based parasite detection method, which is less sensitive
than PCR [22,23], might have missed some low parasitaemia
infections in children classified as parasite negative. The interac-
tion between parasite positive/negative status and ML ratio in
predicting risk of clinical malaria is likely to be dynamic and a
better understanding of these relationships will be gained from
future studies with more frequent sampling of ML ratio and PCR-
based monitoring for both asymptomatic P. falciparum infections
and clinical malaria episodes. Finally, we did not assess the
presence of co-infections, either at cross-sectional survey or during
monitoring for clinical malaria episodes. Thus, the effect of
potential helminth, bacterial or viral co-infections on the
relationship between ML ratio and clinical malaria will need to
be examined in future studies.
Despite these limitations our results support an association
between high ML ratio at recruitment to cross-sectional surveys
and increased risk of clinical malaria during follow-up. This
observation now needs to be confirmed in other geographic
settings.
Acknowledgments
This study was published with the permission of the Director of the Kenya
Medical Research Institute.
Author Contributions
Reviewed and provided inputs to the manuscript draft: GMW LMM GK
GMN JW VN HAF AVSH PB FHAO KM. Conceived and designed the
experiments: GMW KM HAF VN FHAO AVSH. Performed the
experiments: GMN JW KM LMM GK FHAO. Analyzed the data:
GMW PB LMM GK FHAO. Wrote the paper: GMW.
Monocyte to Lymphocyte Ratio and Malaria Risk
PLOS ONE | www.plosone.org 6 February 2013 | Volume 8 | Issue 2 | e57320
References
1. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012)
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet
379: 413–431.
2. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN (2005)
Heritability of malaria in Africa. PLoS Med 2: e340.
3. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, et al.
(1987) Mortality and morbidity from malaria among children in a rural area of
The Gambia, West Africa. Trans R Soc Trop Med Hyg 81: 478–486.
4. Marsh K (1992) Malaria–a neglected disease? Parasitology 104 Suppl: S53–69.
5. Lines J, Armstrong JR (1992) For a few parasites more: Inoculum size, vector
control and strain-specific immunity to malaria. Parasitol Today 8: 381–383.
6. Marsh K, Kinyanjui S (2006) Immune effector mechanisms in malaria. Parasite
Immunol 28: 51–60.
7. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, et al. (1998) Parasite
antigens on the infected red cell surface are targets for naturally acquired
immunity to malaria. Nat Med 4: 358–360.
8. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, et al. (2008) Breadth and
magnitude of antibody responses to multiple Plasmodium falciparum merozoite
antigens are associated with protection from clinical malaria. Infect Immun 76:
2240–2248.
9. Williams TN, Mwangi TW, Wambua S, Peto TE, Weatherall DJ, et al. (2005)
Negative epistasis between the malaria-protective effects of alpha+-thalassemia
and the sickle cell trait. Nat Genet 37: 1253–1257.
10. Bull PC, Lowe BS, Kaleli N, Njuga F, Kortok M, et al. (2002) Plasmodium
falciparum infections are associated with agglutinating antibodies to parasite-
infected erythrocyte surface antigens among healthy Kenyan children. J Infect
Dis 185: 1688–1691.
11. Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K (2004) Protection
against clinical malaria by heterologous immunoglobulin G antibodies against
malaria-infected erythrocyte variant surface antigens requires interaction with
asymptomatic infections. J Infect Dis 190: 1527–1533.
12. Mackintosh CL, Mwangi T, Kinyanjui SM, Mosobo M, Pinches R, et al. (2008)
Failure to respond to the surface of Plasmodium falciparum infected erythrocytes
predicts susceptibility to clinical malaria amongst African children. Int J Parasitol
38: 1445–1454.
13. Ladhani S, Lowe B, Cole AO, Kowuondo K, Newton CR (2002) Changes in
white blood cells and platelets in children with falciparum malaria: relationship
to disease outcome. Br J Haematol 119: 839–847.
14. Maina RN, Walsh D, Gaddy C, Hongo G, Waitumbi J, et al. (2010) Impact of
Plasmodium falciparum infection on haematological parameters in children
living in Western Kenya. Malar J 9 Suppl 3: S4.
15. Olliaro P, Djimde A, Dorsey G, Karema C, Martensson A, et al. (2011)
Hematologic parameters in pediatric uncomplicated Plasmodium falciparum
malaria in sub-Saharan Africa. Am J Trop Med Hyg 85: 619–625.
16. Hanscheid T, Langin M, Lell B, Potschke M, Oyakhirome S, et al. (2008) Full
blood count and haemozoin-containing leukocytes in children with malaria:
diagnostic value and association with disease severity. Malar J 7: 109.
17. Scott JA, Bauni E, Moisi JC, Ojal J, Gatakaa H, et al. (2012) Profile: The Kilifi
Health and Demographic Surveillance System (KHDSS). Int J Epidemiol 41:
650–657.
18. Midega JT, Smith DL, Olotu A, Mwangangi JM, Nzovu JG, et al. (2012) Wind
direction and proximity to larval sites determines malaria risk in Kilifi District in
Kenya. Nat Commun 3: 674.
19. Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, et al. (2007) The decline
in paediatric malaria admissions on the coast of Kenya. Malar J 6: 151.
20. Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, et al. (2006) A phase 2b
randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA
ME-TRAP among children in Kenya. PLoS Clin Trials 1: e29.
21. Mwangi TW, Ross A, Snow RW, Marsh K (2005) Case definitions of clinical
malaria under different transmission conditions in Kilifi District, Kenya. J Infect
Dis 191: 1932–1939.
22. Bejon P, Andrews L, Hunt-Cooke A, Sanderson F, Gilbert SC, et al. (2006)
Thick blood film examination for Plasmodium falciparum malaria has reduced
sensitivity and underestimates parasite density. Malar J 5: 104.
23. Manning L, Laman M, Rosanas-Urgell A, Turlach B, Aipit S, et al. (2012)
Rapid antigen detection tests for malaria diagnosis in severely ill Papua New
Guinean children: a comparative study using Bayesian latent class models. PLoS
One 7: e48701.
24. Rhee MS, Akanmori BD, Waterfall M, Riley EM (2001) Changes in cytokine
production associated with acquired immunity to Plasmodium falciparum
malaria. Clin Exp Immunol 126: 503–510.
25. Walther M, Woodruff J, Edele F, Jeffries D, Tongren JE, et al. (2006) Innate
immune responses to human malaria: heterogeneous cytokine responses to
blood-stage Plasmodium falciparum correlate with parasitological and clinical
outcomes. J Immunol 177: 5736–5745.
26. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, et al. (1999) A low
interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria
anemia in children residing in a holoendemic malaria region in western Kenya.
J Infect Dis 179: 279–282.
27. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, et al. (2002) Absolute
levels and ratios of proinflammatory and anti-inflammatory cytokine production
in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis
185: 971–979.
28. Dunachie SJ, Berthoud T, Keating SM, Hill AV, Fletcher HA (2010) MIG and
the regulatory cytokines IL-10 and TGF-beta1 correlate with malaria vaccine
immunogenicity and efficacy. PLoS One 5: e12557.
Monocyte to Lymphocyte Ratio and Malaria Risk
PLOS ONE | www.plosone.org 7 February 2013 | Volume 8 | Issue 2 | e57320
